Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $220.78 million. The enterprise value is $140.99 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 56.46 million shares outstanding. The number of shares has increased by 15.74% in one year.
| Current Share Class | 56.46M |
| Shares Outstanding | 56.46M |
| Shares Change (YoY) | +15.74% |
| Shares Change (QoQ) | +35.93% |
| Owned by Insiders (%) | 2.87% |
| Owned by Institutions (%) | 16.85% |
| Float | 32.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 57.96 |
| Forward PS | 60.90 |
| PB Ratio | 5.05 |
| P/TBV Ratio | 5.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 50.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.37.
| Current Ratio | 4.73 |
| Quick Ratio | 4.64 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.32 |
Financial Efficiency
Return on equity (ROE) is -166.97% and return on invested capital (ROIC) is -87.22%.
| Return on Equity (ROE) | -166.97% |
| Return on Assets (ROA) | -52.21% |
| Return on Invested Capital (ROIC) | -87.22% |
| Return on Capital Employed (ROCE) | -89.41% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | $40,257 |
| Profits Per Employee | -$1.07M |
| Employee Count | 70 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.11% in the last 52 weeks. The beta is 0.60, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -34.11% |
| 50-Day Moving Average | 4.36 |
| 200-Day Moving Average | 3.38 |
| Relative Strength Index (RSI) | 46.17 |
| Average Volume (20 Days) | 219,111 |
Short Selling Information
The latest short interest is 787,226, so 1.39% of the outstanding shares have been sold short.
| Short Interest | 787,226 |
| Short Previous Month | 737,127 |
| Short % of Shares Out | 1.39% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 3.74 |
Income Statement
In the last 12 months, OBIO had revenue of $2.82 million and -$75.10 million in losses. Loss per share was -$1.80.
| Revenue | 2.82M |
| Gross Profit | 2.62M |
| Operating Income | -75.24M |
| Pretax Income | -75.10M |
| Net Income | -75.10M |
| EBITDA | -74.91M |
| EBIT | -75.24M |
| Loss Per Share | -$1.80 |
Full Income StatementBalance Sheet
The company has $95.82 million in cash and $16.04 million in debt, with a net cash position of $79.79 million or $1.41 per share.
| Cash & Cash Equivalents | 95.82M |
| Total Debt | 16.04M |
| Net Cash | 79.79M |
| Net Cash Per Share | $1.41 |
| Equity (Book Value) | 43.74M |
| Book Value Per Share | 0.77 |
| Working Capital | 77.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$60.23 million and capital expenditures -$562,000, giving a free cash flow of -$60.79 million.
| Operating Cash Flow | -60.23M |
| Capital Expenditures | -562,000 |
| Free Cash Flow | -60.79M |
| FCF Per Share | -$1.08 |
Full Cash Flow StatementMargins
| Gross Margin | 93.01% |
| Operating Margin | -2,669.91% |
| Pretax Margin | -2,665.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.74% |
| Shareholder Yield | -15.74% |
| Earnings Yield | -34.02% |
| FCF Yield | -27.54% |
Analyst Forecast
The average price target for OBIO is $14.25, which is 261.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.25 |
| Price Target Difference | 261.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 87.20% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -4.82 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.82 |
| Piotroski F-Score | 4 |
